FDA Inspection 1307088 — OMNILIFE USA, INC.
The FDA completed an inspection of OMNILIFE USA, INC. on March 9, 2026 in Plano, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 9, 2026
- Fiscal Year
- 2026
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Plano, TX (United States)
Additional Details
FSVP